| Putative DNA quadruplex formation within the human c-kit oncogene. | None |
| A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E. | None |
| A disease with striking similarities to human mastocytosis develops spontaneously in transgenic mice expressing the human Asp816Val mutant Kit protooncogene specifically in Mast Cells. | None |
| Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. | None |
| A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene. | None |
| Expression of c-kit proto-oncogene in canine mastocytoma: a kinetic study using real-time polymerase chain reaction. | None |
| Identification of a ligand for the c-kit proto-oncogene. | None |
| Developmental expression of c-kit, a proto-oncogene encoded by the W locus. | None |
| Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene. | None |
| Acquired resistance of GIST to imatinib mesylate appears to be linked to a novel mutation in Proto-Oncogene Proteins c-kit. | None |
| Expression of the c-kit proto-oncogene in the murine male germ cells. | None |
| An SstI RFLP at the C-Kit oncogene locus (KIT). | None |
| Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. | None |
| Semaxinib (SU5416) as a therapeutic agent targeting oncogenic Kit mutants resistant to imatinib mesylate. | None |
| Expression of c-KIT oncoprotein in gastrointestinal stromal tumors in adults and children: guideline for diagnosis and treatment. | None |
| IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. | None |
| TaqI RFLP at the c-kit oncogene locus (KIT). | None |
| KIT may have a significant role in the oncogenesis of mesenchymal tumours of the uterus and ovary. | None |
| Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate. | None |
| KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance. | None |